Screener / SEC EDGAR /CIK 0001306830 /10-K filed Feb 24, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)

Celanese Corp CE

Compare with peers Embed
Earnings releases

Latest results release: Nov 2, 2026

8-K item 2.02, exhibit 99

What CE's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Nov 2, 2026, CE reported $0.68 per share under GAAP and $1.65 on its own adjusted basis: the adjusted number is +143% above GAAP.

GAAP EPS $6.43, release Feb 20, 2024: Celanese also reported fourth quarter GAAP diluted earnings per share of $6.43 and adjusted earnings per share of $2.24. Adjusted EPS $2.24, release Feb 20, 2024: Celanese also reported fourth quarter GAAP diluted earnings per share of $6.43 and adjusted earnings per share of $2.24. -65% 2024-02 GAAP EPS $1.10, release May 8, 2024: GAAP diluted earnings per share of $1.10 and adjusted earnings per share of $2.08. Adjusted EPS $2.08, release May 8, 2024: GAAP diluted earnings per share of $1.10 and adjusted earnings per share of $2.08. +89% 2024-05 GAAP EPS $1.42, release Aug 1, 2024: GAAP diluted earnings per share of $1.42 and adjusted earnings per share of $2.38. Adjusted EPS $2.38, release Aug 1, 2024: GAAP diluted earnings per share of $1.42 and adjusted earnings per share of $2.38. +68% 2024-08 GAAP EPS $1.08, release Nov 4, 2024: GAAP diluted earnings per share of $1.08 and adjusted earnings per share of $2.44. Adjusted EPS $2.44, release Nov 4, 2024: GAAP diluted earnings per share of $1.08 and adjusted earnings per share of $2.44. +126% 2024-11 GAAP EPS $-0.15, release May 5, 2025: GAAP diluted loss per share of $0.15 and adjusted earnings per share of $0.57. Adjusted EPS $0.57, release May 5, 2025: GAAP diluted loss per share of $0.15 and adjusted earnings per share of $0.57. 2025-05 GAAP EPS $1.90, release Aug 11, 2025: GAAP diluted earnings per share of $1.90 and adjusted earnings per share of $1.44. Adjusted EPS $1.44, release Aug 11, 2025: GAAP diluted earnings per share of $1.90 and adjusted earnings per share of $1.44. -24% 2025-08 GAAP EPS $-12.39, release Nov 6, 2025: GAAP diluted loss per share of ($12.39) and adjusted earnings per share of $1.34. Adjusted EPS $1.34, release Nov 6, 2025: GAAP diluted loss per share of ($12.39) and adjusted earnings per share of $1.34. 2025-11 GAAP EPS $0.23, release Feb 17, 2026: GAAP diluted earnings per share of $0.23 and adjusted earnings per share of $0.67. Adjusted EPS $0.67, release Feb 17, 2026: GAAP diluted earnings per share of $0.23 and adjusted earnings per share of $0.67. +191% 2026-02 GAAP EPS $0.41, release May 5, 2026: GAAP diluted earnings per share of $0.41 and adjusted earnings per share of $0.85. Adjusted EPS $0.85, release May 5, 2026: GAAP diluted earnings per share of $0.41 and adjusted earnings per share of $0.85. +107% 2026-05 GAAP EPS $1.15, release Aug 4, 2026: GAAP diluted earnings per share of $1.15 and adjusted earnings per share of $2.45. Adjusted EPS $2.45, release Aug 4, 2026: GAAP diluted earnings per share of $1.15 and adjusted earnings per share of $2.45. +113% 2026-08 GAAP EPS $0.68, release Nov 2, 2026: GAAP diluted earnings per share of $0.68 and adjusted earnings per share of $1.65. Adjusted EPS $1.65, release Nov 2, 2026: GAAP diluted earnings per share of $0.68 and adjusted earnings per share of $1.65. +143% 2026-11
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
GAAP diluted earnings per share of $0.68 and adjusted earnings per share of $1.65. release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 2, 2026 · EX-99.1

Celanese Corporation Reports Third Quarter Earnings;

Open on SEC

Exceeds Third Quarter Guidance and Raises Full Year Outlook Dallas, November 2, 2026: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported third quarter 2026 U.S. GAAP diluted earnings per share of $0.68 and adjusted earnings per share of $1.65. Net sales of $2.6 billion increased 6 percent compared to the same period in 2025 and were driven by progress on strategic growth initiatives and commercial actions across the portfolio. Sequentially, net sales decreased 7 percent, reflecting expected moderation from the second quarter.

For the third quarter, the Company reported consolidated operating profit of $198 million, adjusted EBIT of $367 million, and operating EBITDA of $548 million at margins of 8, 14, and 21 percent, respectively. These results reflect disciplined execution across the Company, commercial execution, and the resilience of the Company's differentiated businesses.

Celanese has continued to take actions that demonstrate its ability to improve earnings while generating substantial cash flow to drive meaningful progress on deleveraging. In the third quarter, the Company delivered operating cash flow of $538 million and free cash flow of $461 million.

"Our third quarter results demonstrate continued progress across Celanese, with strong earnings performance and net sales growth," said Scott Richardson, president and chief executive officer. "Cash generation in the third quarter was strong, and by the end of 2026 we expect to have generated over $1.5 billion in free cash flow over the past two years, reflecting the benefits of the significant actions we have taken to improve productivity, strengthen commercial execution and enhance the quality of our portfolio. We also continue to advance our objective of generating approximately $1 billion of divestiture sales proceeds by the end of 2027, and expect to reach approximately $650 million by year end. The benefits of our productivity actions and early contributions from strategic growth initiatives are increasingly evident in our results, enhancing earnings quality, strengthening cash generation, and accelerating progress on deleveraging." 1 Third Quarter 2026 Financial Highlights:

• Announced an Investor Event to take place on December 9, 2026 at the Company's technical center and manufacturing site in Florence, Kentucky. Executive management plans to provide details on the Company’s business strategy, growth pathways, and long-term value creation priorities.

• Added Luis Fernandez-Moreno to the Company’s Board of Directors in September 2026. Mr. Fernandez-Moreno most recently served as interim President and Chief Executive officer of Ingevity Corporation, and previously as Senior Vice President at Ashland, Inc. Prior to that, he held various leadership roles at Arch Chemicals, The Dow Chemical Company, and Rohm & Haas Company. Mr. Fernandez-Moreno brings over 40 years of experience and leadership in the performance materials, specialty ingredients and coatings industries spanning corporate strategy, growth and innovation, and mergers and acquisitions.

• Signed a definitive agreement to sell an additional 19 percent of the Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. in a transaction with total cash proceeds of approximately $152 million, while retaining 11 percent interest in the joint venture. The Company expects the transaction to close in the fourth quarter of 2026, subject to certain regulatory approvals and other customary closing conditions.

• Entered into a strategic partnership with VIGOR Precision Ltd., a global leader in precision plastic gears and components, to advance the development and commercialization of lightweight plastic joint solutions for humanoid robots. This further expands Celanese's targeted growth opportunities.

• Completed the previously announced closure of the acetate tow facility in Lanaken, Belgium to further optimize the Company's manufacturing footprint and cost structure. Celanese has successfully leveraged existing resources to continue to meet the needs and expectations of customers.

Engineered Materials reported third quarter net sales of $1.4 billion, a 1 percent decrease year over year; however, 2025 sales included the divested Micromax ® business that contributed 6 percent to the year over year decline. The results reflected continued momentum in the business's strategic growth initiatives and disciplined commercial execution. Growth in medical and electronics applications continued to support favorable mix enrichment and earnings improvement during the quarter. Sequentially, net sales declined 5 percent, mainly driven by sequential automotive declines partially offset by strength in medical and electronics. The business reported third quarter operating profit of $161 million, adjusted EBIT of $209 million, and operating EBITDA of $311 million, with margins of 12, 15, and 23 percent, respectively. Results were supported by strong commercial execution, favorable product mix, and early contributions from a number of strategic growth initiatives, which more than offset raw material inflation and higher logistics costs. The business continues to make meaningful progress in advancing a number of targeted initiatives that support both growth and competitiveness, with progress of the planned expansions of specialty compounding operations in Europe, beginning commissioning activities for the liquid crystal polymer production facility in Asia, and advancing new medical-grade compounding capabilities in Asia. The business remains on track to commercialize all three projects during the first half of 2027. 3

The Acetyl Chain reported third quarter net sales of $1.2 billion, a 14 percent increase compared to the same period in 2025. During the quarter, the Acetyl Chain delivered strong performance across acetic acid, derivatives, and the vinyls chain, as modest demand softness was more than offset by pricing favorability and incremental spot opportunities. Sequentially, net sales declined 9 percent, reflecting anticipated moderation from normalizing supply chains. The quarter developed largely as expected and reflected continued strength across the business despite periods of volatility. The business deliver ed third quarter operating profit of $141 million, adjusted EBIT of $236 million, and operating EBITDA of $301 million at margins of 12, 20, and 25 percent, respectively. Performance in the quarter once again highlighted the strength of the Acetyl Chain's integrated business model, the benefits of its flexible operating network, and its ability to capture value across regions in a dynamic environment.

Celanese reported third quarter operating cash flow of $538 million and free cash flow of $461 million, with year to date operating cash flow of $823 million and free cash flow of $604 million, supported by anticipated working capital timing benefits and continued discipline in capital expenditures.

The effective U.S. GAAP income tax rate for the third quarter was 15 percent, higher than same period in 2025, p rimarily due to a non-cash goodwill impairment loss of $1.1 billion in the Engineered Materials segment recorded during the prior year, which is not deductible for tax purposes. The effective tax rate for 2026 adjusted earnings was 8 percent for the third quarter, and we anticipate this rate for the full year 2026 based on expected full year jurisdictional earnings mix and consideration of other non-recurring U.S. GAAP items.

"Looking to the fourth quarter, we expect year-end seasonal moderation across both businesses. We will continue to drive our strategic initiatives, our targeted growth areas, as well as our cost reduction and productivity prog rams," continued Richardson. "Ba sed on these dynamics, we anticipate full-year 2026 adjusted earnings per share of approximately $6.00 to $6.25. In addition, based on our strong execution year to date, we have increased our free cash flow outlook to a range of $750 to $800 million."

"While conditions remain dynamic, the progress we are seeing across our productivity initiatives, strategic growth platforms, and cash generation efforts give us confidence in our ability to continue improving the earnings power of the company over time. We also expect to exit the year with net debt- to-operating EBITDA of approximately 4.7x, reflecting the progress we have made on deleveraging through disciplined cash generation, targeted divestitures, and focused capital allocation. We remain focused on continuing to strengthen the balance sheet, improving the quality and durability of earnings, and creating long-term shareholder value through disciplined execution of our growth and strategic initiatives," Richardson concluded.

Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent U.S. GAAP measures (diluted earnings per share, net earnings (loss) attributable to Celanese Corporation and net cash provided by (used in) operations, respectively), are not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, and other items is not practical. For more information, see "Non-GAAP Financial Measures" below. 4 The Company's prepared remarks related to the third quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on November 2, 2026. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.

Contacts: Investor Media - U.S. Media - Europe Media - Asia Relations Bill Cunningham Jamaison Schuler Petra Czugler Maria Xia Phone: +1 302 Phone: +1 972 Phone: +49 69 Phone: +86 21 772 5231 443 4400 45009 1206 3861 9368 william.cunnin… media@celanese.… petra.czugler@c… maria.xia@celane…

Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2025 net sales of $9.5 billion.

This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness and our financial condition, each of which could diminish our ability to raise additional capital to fund operations, reduce our business and strategic flexibility, increase our interest expense, limit the success of our deleveraging efforts, and impact changes to our credit ratings, which could increase our interest expense in the event of additional downgrades; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; additional impairment of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, AI-related vulnerabilities, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of fire, flood, hurricanes, other severe weather, natural disasters, other catastrophic events, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties, treaties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain. 5 Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for operating EBITDA margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

• Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales.

• Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We do not provide reconciliations for operating EBITDA on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark- to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Operating EBITDA margin is defined by the Company as operating EBITDA divided by net sales.

• Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark- to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

• Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our noncontrolling interest joint ventures. We do not provide reconciliations for free cash flow on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of items such as working capital changes, fluctuations in foreign currency exchange rates, the impact and timing of potential acquisitions and divestitures, and other structural changes, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about November 2, 2026 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year. 6 Beginning with the reporting period ending June 30, 2026, the Company revised its presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. Previously, Other Income (Expense) Attributable to Celanese Corporation was included with the presentation of Equity Earnings and Dividend Income Attributable to Celanese Corporation. To provide a better understanding for readers of the U.S. GAAP results of the Company’s non-consolidated equity investments by presenting such results in isolation and better align with how management assesses such results, Other Income (Expense) Attributable to Celanese Corporation is now included with Non-Operating Pension, Other Post- Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation. Prior periods presented have been revised to reflect this change.

Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2026.

Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document. 7

September Three Months September 30, June 30, 30, Ended 2026 2026 2025 ────────────────────────────────────────────────────────────────────────────── -In $ millions, except share and per share data Net sales 2,556 2,752 2,419 Cost of -2,017 -2,134 -1,898 sales Gross profit 539 618 521 Selling, general and -248 -251 -231 administrat… expenses Amortization of -40 -39 -42 intangible assets Research and development -29 -29 -31 expenses Other (charges) -32 -31 -1,491 gains, net Foreign exchange 12 10 2 gain (loss), net Gain (loss) on disposition of -4 -2 -3 businesses and assets, net Operating profit 198 276 -1,275 (loss) Equity in net earnings 9 11 39 (loss) of affiliates Non-operati… pension and other postretirem… 5 5 2 employee benefit (expense) income Interest -175 -186 -177 expense Interest 6 10 7 income Dividend income - 44 43 40 equity investments Other income (expense), 6 -17 4 net Earnings (loss) from continuing 93 142 -1,360 operations before tax Income tax (provision) -14 -11 7 benefit Earnings (loss) from 79 131 -1,353 continuing operations Earnings (loss) from operation of -2 -2 — discontinued operations Income tax (provision) benefit from 1 — — discontinued operations Earnings (loss) from -1 -2 — discontinued operations Net earnings 78 129 -1,353 (loss) Net (earnings) loss attributable -4 -4 -4 to noncontroll… interests Net earnings (loss) attributable 74 125 -1,357 to Celanese Corporation Amounts attributable to Celanese Corporation Earnings (loss) from 75 127 -1,357 continuing operations Earnings (loss) from -1 -2 — discontinued operations Net earnings 74 125 -1,357 (loss) Earnings (loss) per common share - basic Continuing 0.68 1.16 -12.39 operations Discontinued -0.01 -0.02 — operations Net earnings (loss) - 0.67 1.14 -12.39 basic Earnings (loss) per common share - diluted Continuing 0.68 1.15 -12.39 operations Discontinued -0.01 -0.02 — operations Net earnings (loss) - 0.67 1.13 -12.39 diluted Weighted average shares (in millions) Basic 109.8 109.8 109.6 Diluted 110.2 110.2 109.6

As of As of September 30, December 31, 2026 2025 ────────────────────────────────────────────────────────────────────────────── -In $ millions ASSETS Current Assets Cash and cash equivalents 1,362 1,263 Trade receivables - third party and 960 922 affiliates, net Non-trade receivables, net 624 545 Inventories 2,286 2,220 Assets held for sale — 492 Other assets 258 251 Total current assets 5,490 5,693 Investments in affiliates 1,267 1,252 Property, plant and 4,715 5,076 equipment, net Operating lease 426 359 right-of-use assets Deferred income taxes 1,279 1,359 Other assets 571 601 Goodwill 4,150 4,171 Intangible assets, net 3,036 3,184 Total assets 20,934 21,695 LIABILITIES AND EQUITY Current Liabilities Short-term borrowings and current installments of long-term 1,414 1,204 debt - third party and affiliates Trade payables - third party and 1,315 1,279 affiliates Liabilities held for sale — 75 Other liabilities 1,479 1,049 Income taxes payable 142 76 Total current liabilities 4,350 3,683 Long-term debt, net of unamortized 10,131 11,394 deferred financing costs Deferred income taxes 369 512 Uncertain tax positions 222 208 Benefit obligations 312 344 Operating lease 329 265 liabilities Other liabilities 586 817 Commitments and Contingencies Shareholders' Equity Treasury stock, at cost -5,480 -5,482 Additional paid-in capital 459 431 Retained earnings 10,109 9,876 Accumulated other comprehensive income -872 -776 (loss), net Total Celanese Corporation shareholders' 4,216 4,049 equity Noncontrolling interests 419 423 Total equity 4,635 4,472 Total liabilities and 20,934 21,695 equity

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
              Celanese Corporation Reports Third Quarter Earnings;              
                                                                                
          Exceeds Third Quarter Guidance and Raises Full Year Outlook           
Dallas, November 2, 2026: Celanese Corporation (NYSE: CE), a global chemical and
specialty materials company, today reported third quarter 2026 U.S. GAAP diluted
earnings per share of $0.68 and adjusted earnings per share of $1.65. Net sales
of $2.6 billion increased 6 percent compared to the same period in 2025 and were
driven by progress on strategic growth initiatives and commercial actions across
the portfolio. Sequentially, net sales decreased 7 percent, reflecting expected
moderation from the second quarter.

For the third quarter, the Company reported consolidated operating profit of
$198 million, adjusted EBIT of $367 million, and operating EBITDA of $548
million at margins of 8, 14, and 21 percent, respectively. These results reflect
disciplined execution across the Company, commercial execution, and the
resilience of the Company's differentiated businesses.

Celanese has continued to take actions that demonstrate its ability to improve
earnings while generating substantial cash flow to drive meaningful progress on
deleveraging. In the third quarter, the Company delivered operating cash flow of
$538 million and free cash flow of $461 million.

"Our third quarter results demonstrate continued progress across Celanese, with
strong earnings performance and net sales growth," said Scott Richardson,
president and chief executive officer. "Cash generation in the third quarter was
strong, and by the end of 2026 we expect to have generated over $1.5 billion in
free cash flow over the past two years, reflecting the benefits of the
significant actions we have taken to improve productivity, strengthen commercial
execution and enhance the quality of our portfolio. We also continue to advance
our objective of generating approximately $1 billion of divestiture sales
proceeds by the end of 2027, and expect to reach approximately $650 million by
year end. The benefits of our productivity actions and early contributions from
strategic growth initiatives are increasingly evident in our results, enhancing
earnings quality, strengthening cash generation, and accelerating progress on
deleveraging."
                                       1                                        
Third Quarter 2026 Financial Highlights:
                                                                                
                 Three                                                          
                 Months                                                         
                 Ended                                                          
                 September                                September             
                 30,                   June 30,           30,                   
                 2026                  2026               2025                  
 ────────────────────────────────────────────────────────────────────────────── 
                 -unaudited                                                     
                 -In $                                                          
                 millions,                                                      
                 except per                                                     
                 share data                                                     
  Net Sales                                                                     
  Engineered                  1,368              1,446                   1,384  
  Materials                                                                     
  Acetyl                      1,209              1,329                   1,061  
  Chain                                                                         
  Intersegme…                   -21                -23                     -26  
  Eliminatio…                                                                   
  Total                       2,556              2,752                   2,419  
  Operating                                                                     
  Profit                                                                        
  (Loss)                                                                        
  Engineered                    161                156                  -1,327  
  Materials                                                                     
  Acetyl                        141                237                     135  
  Chain                                                                         
  Other                        -104               -117                     -83  
  Activities                                                                    
  Total                         198                276                  -1,275  
  Net                                                                           
  Earnings                       78                129                  -1,353  
  (Loss)                                                                        
  Adjusted                                                                      
  EBIT(1)                                                                       
  Engineered                    209                234                     200  
  Materials                                                                     
  Acetyl                        236                321                     187  
  Chain                                                                         
  Other                         -78                -85                     -61  
  Activities                                                                    
  Total                         367                470                     326  
  Equity                                                                        
  Earnings                                                                      
  and                                                                           
  Dividend                                                                      
  Income                                                                        
  Engineered                      3                  6                      33  
  Materials                                                                     
  Acetyl                         47                 44                      43  
  Chain                                                                         
  Operating                     548                649                     517  
  EBITDA(1)                                                                     
  Diluted EPS                                                                   
  -              $             0.68    $          1.15    $             -12.39  
  continuing                                                                    
  operations                                                                    
  Diluted EPS    $             0.67    $          1.13    $             -12.39  
  - total                                                                       
  Adjusted       $             1.65    $          2.45    $               1.34  
  EPS(1)                                                                        
  Net cash                                                                      
  provided by                                                                   
  (used in)                     -70                -59                     -59  
  investing                                                                     
  activities                                                                    
  Net cash                                                                      
  provided by                                                                   
  (used in)                    -480               -546                    -118  
  financing                                                                     
  activities                                                                    
  Net cash                                                                      
  provided by                                                                   
  (used in)                     538                209                     447  
  operating                                                                     
  activities                                                                    
  Free cash                     461                140                     375  
  flow(1)                                                                       
                                                                                
____________________________

(1) See "Non-US GAAP Financial Measures" below.
                                       2                                        
Recent Highlights:

• Announced an Investor Event to take place on December 9, 2026 at the Company's
technical center and manufacturing site in Florence, Kentucky. Executive
management plans to provide details on the Company’s business strategy, growth
pathways, and long-term value creation priorities.

• Added Luis Fernandez-Moreno to the Company’s Board of Directors in September
2026. Mr. Fernandez-Moreno most recently served as interim President and Chief
Executive officer of Ingevity Corporation, and previously as Senior Vice
President at Ashland, Inc. Prior to that, he held various leadership roles at
Arch Chemicals, The Dow Chemical Company, and Rohm & Haas Company. Mr.
Fernandez-Moreno brings over 40 years of experience and leadership in the
performance materials, specialty ingredients and coatings industries spanning
corporate strategy, growth and innovation, and mergers and acquisitions.

• Signed a definitive agreement to sell an additional 19 percent of the
Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. in a transaction
with total cash proceeds of approximately $152 million, while retaining 11
percent interest in the joint venture. The Company expects the transaction to
close in the fourth quarter of 2026, subject to certain regulatory approvals and
other customary closing conditions.

• Entered into a strategic partnership with VIGOR Precision Ltd., a global
leader in precision plastic gears and components, to advance the development and
commercialization of lightweight plastic joint solutions for humanoid robots.
This further expands Celanese's targeted growth opportunities.

• Completed the previously announced closure of the acetate tow facility in
Lanaken, Belgium to further optimize the Company's manufacturing footprint and
cost structure. Celanese has successfully leveraged existing resources to
continue to meet the needs and expectations of customers.
                                                                                
   Third Quarter Business Segment Overview                                      
                                                                                
                                                                                
  Engineered Materials                                                          
                                                                                
Engineered Materials reported third quarter net sales of $1.4 billion, a 1
percent decrease year over year; however, 2025 sales included the divested
Micromax ® business that contributed 6 percent to the year over year decline.
The results reflected continued momentum in the business's strategic growth
initiatives and disciplined commercial execution. Growth in medical and
electronics applications continued to support favorable mix enrichment and
earnings improvement during the quarter. Sequentially, net sales declined 5
percent, mainly driven by sequential automotive declines partially offset by
strength in medical and electronics. The business reported third quarter
operating profit of $161 million, adjusted EBIT of $209 million, and operating
EBITDA of $311 million, with margins of 12, 15, and 23 percent, respectively.
Results were supported by strong commercial execution, favorable product mix,
and early contributions from a number of strategic growth initiatives, which
more than offset raw material inflation and higher logistics costs. The business
continues to make meaningful progress in advancing a number of targeted
initiatives that support both growth and competitiveness, with progress of the
planned expansions of specialty compounding operations in Europe, beginning
commissioning activities for the liquid crystal polymer production facility in
Asia, and advancing new medical-grade compounding capabilities in Asia. The
business remains on track to commercialize all three projects during the first
half of 2027.
                                       3                                        
                                                                                
  Acetyl Chain                                                                  
                                                                                
The Acetyl Chain reported third quarter net sales of $1.2 billion, a 14 percent
increase compared to the same period in 2025. During the quarter, the Acetyl
Chain delivered strong performance across acetic acid, derivatives, and the
vinyls chain, as modest demand softness was more than offset by pricing
favorability and incremental spot opportunities. Sequentially, net sales
declined 9 percent, reflecting anticipated moderation from normalizing supply
chains. The quarter developed largely as expected and reflected continued
strength across the business despite periods of volatility. The business deliver
ed third quarter operating profit of $141 million, adjusted EBIT of $236
million, and operating EBITDA of $301 million at margins of 12, 20, and 25
percent, respectively. Performance in the quarter once again highlighted the
strength of the Acetyl Chain's integrated business model, the benefits of its
flexible operating network, and its ability to capture value across regions in a
dynamic environment.
                                                                                
  Cash Flow and Tax                                                             
                                                                                
Celanese reported third quarter operating cash flow of $538 million and free
cash flow of $461 million, with year to date operating cash flow of $823 million
and free cash flow of $604 million, supported by anticipated working capital
timing benefits and continued discipline in capital expenditures.

The effective U.S. GAAP income tax rate for the third quarter was 15 percent,
higher than same period in 2025, p rimarily due to a non-cash goodwill
impairment loss of $1.1 billion in the Engineered Materials segment recorded
during the prior year, which is not deductible for tax purposes. The effective
tax rate for 2026 adjusted earnings was 8 percent for the third quarter, and we
anticipate this rate for the full year 2026 based on expected full year
jurisdictional earnings mix and consideration of other non-recurring U.S. GAAP
items.
                                                                                
  Outlook                                                                       
                                                                                
"Looking to the fourth quarter, we expect year-end seasonal moderation across
both businesses. We will continue to drive our strategic initiatives, our
targeted growth areas, as well as our cost reduction and productivity prog
rams," continued Richardson. "Ba sed on these dynamics, we anticipate full-year
2026 adjusted earnings per share of approximately $6.00 to $6.25. In addition,
based on our strong execution year to date, we have increased our free cash flow
outlook to a range of $750 to $800 million."

"While conditions remain dynamic, the progress we are seeing across our
productivity initiatives, strategic growth platforms, and cash generation
efforts give us confidence in our ability to continue improving the earnings
power of the company over time. We also expect to exit the year with net debt-
to-operating EBITDA of approximately 4.7x, reflecting the progress we have made
on deleveraging through disciplined cash generation, targeted divestitures, and
focused capital allocation. We remain focused on continuing to strengthen the
balance sheet, improving the quality and durability of earnings, and creating
long-term shareholder value through disciplined execution of our growth and
strategic initiatives," Richardson concluded.

Reconciliations of forecasted non-GAAP measures such as adjusted earnings per
share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent U.S.
GAAP measures (diluted earnings per share, net earnings (loss) attributable to
Celanese Corporation and net cash provided by (used in) operations,
respectively), are not available without unreasonable efforts because a forecast
of Certain Items, such as mark-to-market pension gains/losses, and other items
is not practical. For more information, see "Non-GAAP Financial Measures" below.
                                       4                                        
The Company's prepared remarks related to the third quarter will be posted on
its website at investors.celanese.com under Financial Information/Financial
Document Library on November 2, 2026. Information about Non-US GAAP measures is
included in a Non-US GAAP Financial Measures and Supplemental Information
document posted on our investor relations website under Financial
Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures"
below.
                                                                                
  Contacts:                                                                     
  Investor           Media - U.S.        Media - Europe      Media - Asia       
  Relations                                                                     
  Bill Cunningham    Jamaison Schuler    Petra Czugler       Maria Xia          
  Phone: +1 302      Phone: +1 972       Phone: +49 69       Phone: +86 21      
  772 5231           443 4400            45009 1206          3861 9368          
  william.cunnin…    media@celanese.…    petra.czugler@c…    maria.xia@celane…  
                                                                                
Celanese Corporation is a global leader in chemistry, producing specialty
material solutions used across most major industries and consumer applications.
Our businesses use our chemistry, technology and commercial expertise to create
value for our customers, employees and shareholders. We support sustainability
by responsibly managing the materials we create and growing our portfolio of
sustainable products to meet customer and societal demand. We strive to make a
positive impact in our communities and to foster inclusivity across our teams.
Celanese Corporation is a Fortune 500 company that employs more than 11,000
employees worldwide with 2025 net sales of $9.5 billion.

Forward-Looking Statements

This release may contain "forward-looking statements," which include information
concerning the Company's plans, objectives, goals, strategies, future revenues,
cash flow, financial performance, synergies, capital expenditures, deleveraging
efforts, planned cost reductions, dividend policy, financing needs and other
information that is not historical information. All forward-looking statements
are based upon current expectations and beliefs and various assumptions. There
can be no assurance that the Company will realize these expectations or that
these beliefs will prove correct. There are a number of risks and uncertainties
that could cause actual results to differ materially from the results expressed
or implied in the forward-looking statements contained in this release. These
risks and uncertainties include, among other things: the ability to successfully
achieve planned cost reductions; changes in general economic, business,
political and regulatory conditions in the countries or regions in which we
operate; the length and depth of product and industry business cycles,
particularly in the automotive, electrical, textiles, electronics and
construction industries; potential liability resulting from pending or future
claims or litigation, including investigations or enforcement actions, or from
changes in the laws, regulations or policies of governments or other
governmental activities, in the countries in which we operate; our level of
indebtedness and our financial condition, each of which could diminish our
ability to raise additional capital to fund operations, reduce our business and
strategic flexibility, increase our interest expense, limit the success of our
deleveraging efforts, and impact changes to our credit ratings, which could
increase our interest expense in the event of additional downgrades; volatility
or changes in the price and availability of raw materials and energy,
particularly changes in the demand for, supply of, and market prices of
ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene
diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas
and fuel oil, and the prices for electricity and other energy sources; the
ability to pass increases in raw materials prices, logistics costs and other
costs on to customers or otherwise improve margins through price increases; the
possibility that we will not be able to realize the anticipated benefits of the
Mobility & Materials business (the "M&M Business") we acquired from DuPont de
Nemours, Inc. (the "M&M Acquisition"), including synergies and growth
opportunities, whether as a result of difficulties arising from the operation of
the M&M Business or other unanticipated delays, costs, inefficiencies or
liabilities; additional impairment of goodwill or intangible assets; increased
commercial, legal or regulatory complexity of entering into, or expanding our
exposure to, certain end markets and geographies; risks in the global economy
and equity and credit markets and their potential impact on our ability to pay
down debt in the future and/or refinance at suitable rates, in a timely manner,
or at all; the ability to maintain plant utilization rates and to implement
planned capacity additions, expansions and maintenance; the ability to reduce or
maintain current levels of production costs and to improve productivity by
implementing technological improvements to existing plants; increased price
competition and the introduction of competing products by other companies; the
ability to identify desirable potential acquisition or divestiture opportunities
and to complete such transactions, including obtaining regulatory approvals,
consistent with the Company's strategy; market acceptance of our products and
technology; compliance and other costs and potential disruption or interruption
of production or operations due to accidents, interruptions in sources of raw
materials, transportation, logistics or supply chain disruptions, cybersecurity
incidents, AI-related vulnerabilities, terrorism or political unrest, public
health crises, or other unforeseen events or delays in construction or operation
of facilities, including as a result of geopolitical conditions, the direct or
indirect consequences of acts of war or conflict (such as the Russia-Ukraine
conflict or conflicts in the Middle East) or terrorist incidents or as a result
of fire, flood, hurricanes, other severe weather, natural disasters, other
catastrophic events, or other crises; the ability to obtain governmental
approvals and to construct facilities on terms and schedules acceptable to the
Company; changes in applicable tariffs, duties, treaties and trade agreements,
tax rates or legislation throughout the world including, but not limited to,
anti-dumping and countervailing duties, adjustments, changes in estimates or
interpretations or the resolution of tax examinations or audits that may impact
recorded or future tax impacts and potential regulatory and legislative tax
developments in the United States and other jurisdictions; changes in the degree
of intellectual property and other legal protection afforded to our products or
technologies, or the theft of such intellectual property; potential liability
for remedial actions and increased costs under existing or future environmental,
health and safety regulations, including those relating to climate change or
other sustainability matters; changes in currency exchange rates and interest
rates; tax rates and changes thereto; and various other factors discussed from
time to time in the Company's filings with the Securities and Exchange
Commission.

Any forward-looking statement speaks only as of the date on which it is made,
and the Company undertakes no obligation to update any forward-looking
statements to reflect events or circumstances after the date on which it is made
or to reflect the occurrence of anticipated or unanticipated events or
circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company's two business segments, Engineered Materials
and the Acetyl Chain.
                                       5                                        
Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted
EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per
share and free cash flow. These measures are not recognized in accordance with
US GAAP and should not be viewed as an alternative to US GAAP measures of
performance or liquidity. The most directly comparable financial measure
presented in accordance with US GAAP in our consolidated financial statements
for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to
Celanese Corporation; for adjusted EBIT margin is operating margin; for
operating EBITDA margin is operating margin; for adjusted earnings per share is
earnings (loss) from continuing operations attributable to Celanese Corporation
per common share-diluted; and for free cash flow is net cash provided by (used
in) operations.

Definitions of Non-US GAAP Financial Measures

• Adjusted EBIT is a performance measure used by the Company and is defined by
the Company as net earnings (loss) attributable to Celanese Corporation, plus
(earnings) loss from discontinued operations, less interest income, plus
interest expense, plus refinancing expense and taxes, and further adjusted for
Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and
Supplemental Information document). We do not provide reconciliations for
adjusted EBIT on a forward-looking basis (including those contained in this
document) when we are unable to provide a meaningful or accurate calculation or
estimation of reconciling items and the information is not available without
unreasonable effort. This is due to the inherent difficulty of forecasting the
timing and amount of Certain Items, such as mark-to-market pension gains and
losses, that have not yet occurred, are out of our control and/or cannot be
reasonably predicted. For the same reasons, we are unable to address the
probable significance of the unavailable information. Adjusted EBIT margin is
defined by the Company as adjusted EBIT divided by net sales.

• Operating EBITDA is a performance measure used by the Company and is defined
by the Company as net earnings (loss) attributable to Celanese Corporation, plus
(earnings) loss from discontinued operations, less interest income, plus
interest expense, plus refinancing expense, taxes and depreciation and
amortization, and further adjusted for Certain Items, which Certain Items
include accelerated depreciation and amortization expense. Operating EBITDA is
equal to adjusted EBIT plus depreciation and amortization. We do not provide
reconciliations for operating EBITDA on a forward-looking basis (including those
contained in this document) when we are unable to provide a meaningful or
accurate calculation or estimation of reconciling items and the information is
not available without unreasonable effort. This is due to the inherent
difficulty of forecasting the timing and amount of Certain Items, such as mark-
to-market pension gains and losses, that have not yet occurred, are out of our
control and/or cannot be reasonably predicted. For the same reasons, we are
unable to address the probable significance of the unavailable information.
Operating EBITDA margin is defined by the Company as operating EBITDA divided by
net sales.

• Adjusted earnings per share is a performance measure used by the Company and
is defined by the Company as earnings (loss) from continuing operations
attributable to Celanese Corporation, adjusted for income tax (provision)
benefit, Certain Items, and refinancing and related expenses, divided by the
number of basic common shares and dilutive restricted stock units and stock
options calculated using the treasury method. We do not provide reconciliations
for adjusted earnings per share on a forward-looking basis (including those
contained in this document) when we are unable to provide a meaningful or
accurate calculation or estimation of reconciling items and the information is
not available without unreasonable effort. This is due to the inherent
difficulty of forecasting the timing and amount of Certain Items, such as mark-
to-market pension gains and losses, that have not yet occurred, are out of our
control and/or cannot be reasonably predicted. For the same reasons, we are
unable to address the probable significance of the unavailable information.

Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments")
is determined using the applicable rates in the taxing jurisdictions in which
the Non-GAAP adjustments occurred and includes both current and deferred income
tax expense (benefit). The income tax rate used for adjusted earnings per share
approximates the midpoint in a range of forecasted tax rates for the year. This
range may include certain partial or full-year forecasted tax opportunities and
related costs, where applicable, and specifically excludes changes in uncertain
tax positions, discrete recognition of GAAP items on a quarterly basis, other
pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share
purposes and changes in management's assessments regarding the ability to
realize deferred tax assets for GAAP. In determining the adjusted earnings per
share tax rate, we reflect the impact of foreign tax credits when utilized, or
expected to be utilized, absent discrete events impacting the timing of foreign
tax credit utilization. We analyze this rate quarterly and adjust it if there is
a material change in the range of forecasted tax rates; an updated forecast
would not necessarily result in a change to our tax rate used for adjusted
earnings per share. The adjusted tax rate is an estimate and may differ from the
actual tax rate used for GAAP reporting in any given reporting period. Table 3a
of our Non-US GAAP Financial Measures and Supplemental Information document
summarizes the reconciliation of our estimated GAAP effective tax rate to the
adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP
items due to our inability to forecast such items. As part of the year-end
reconciliation, we will update the reconciliation of the GAAP effective tax rate
to the adjusted tax rate for actual results.

• Free cash flow is a liquidity measure used by the Company and is defined by
the Company as net cash provided by (used in) operations, less capital
expenditures on property, plant and equipment, and adjusted for contributions
from or distributions to our noncontrolling interest joint ventures. We do not
provide reconciliations for free cash flow on a forward-looking basis (including
those contained in this document) when we are unable to provide a meaningful or
accurate calculation or estimation of reconciling items and the information is
not available without unreasonable effort. This is due to the inherent
difficulty of forecasting the timing and amount of items such as working capital
changes, fluctuations in foreign currency exchange rates, the impact and timing
of potential acquisitions and divestitures, and other structural changes, that
have not yet occurred, are out of our control and/or cannot be reasonably
predicted. For the same reasons, we are unable to address the probable
significance of the unavailable information.

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this press release
to the comparable US GAAP financial measure, together with information about the
purposes and uses of Non-US GAAP financial measures, are included in our Non-US
GAAP Financial Measures and Supplemental Information document filed as an
exhibit to our Current Report on Form 8-K filed with the SEC on or about
November 2, 2026 and also available on our website at investors.celanese.com
under Financial Information/Financial Document Library.

Results Unaudited

The results in this document, together with the adjustments made to present the
results on a comparable basis, have not been audited and are based on internal
financial data furnished to management. Quarterly results should not be taken as
an indication of the results of operations to be reported for any subsequent
period or for the full fiscal year.
                                       6                                        
Beginning with the reporting period ending June 30, 2026, the Company revised
its presentation of Equity Earnings and Dividend Income Attributable to Celanese
Corporation. Previously, Other Income (Expense) Attributable to Celanese
Corporation was included with the presentation of Equity Earnings and Dividend
Income Attributable to Celanese Corporation. To provide a better understanding
for readers of the U.S. GAAP results of the Company’s non-consolidated equity
investments by presenting such results in isolation and better align with how
management assesses such results, Other Income (Expense) Attributable to
Celanese Corporation is now included with Non-Operating Pension, Other Post-
Retirement Employee Benefit (Expense) Income Attributable to Celanese
Corporation. Prior periods presented have been revised to reflect this change.

Certain prior period amounts have been revised to correct for certain prior
period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for
the quarterly period ending June 30, 2026.

Supplemental Information

Additional information about our prior period performance is included in our
Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and
Supplemental Information document.
                                       7                                        
                                                                                
  Consolidated Statements of Operations - Unaudited                             
                                                                                
                                                                                
                                                                     September  
                  Three Months   September 30,      June 30,               30,  
                  Ended                   2026          2026              2025  
 ────────────────────────────────────────────────────────────────────────────── 
                  -In $                                                         
                  millions,                                                     
                  except share                                                  
                  and per share                                                 
                  data                                                          
  Net sales                              2,556         2,752             2,419  
  Cost of                               -2,017        -2,134            -1,898  
  sales                                                                         
  Gross profit                             539           618               521  
  Selling,                                                                      
  general and                             -248          -251              -231  
  administrat…                                                                  
  expenses                                                                      
  Amortization                                                                  
  of                                       -40           -39               -42  
  intangible                                                                    
  assets                                                                        
  Research and                                                                  
  development                              -29           -29               -31  
  expenses                                                                      
  Other                                                                         
  (charges)                                -32           -31            -1,491  
  gains, net                                                                    
  Foreign                                                                       
  exchange                                  12            10                 2  
  gain (loss),                                                                  
  net                                                                           
  Gain (loss)                                                                   
  on                                                                            
  disposition                                                                   
  of                                        -4            -2                -3  
  businesses                                                                    
  and assets,                                                                   
  net                                                                           
  Operating                                                                     
  profit                                   198           276            -1,275  
  (loss)                                                                        
  Equity in                                                                     
  net earnings                               9            11                39  
  (loss) of                                                                     
  affiliates                                                                    
  Non-operati…                                                                  
  pension and                                                                   
  other                                                                         
  postretirem…                               5             5                 2  
  employee                                                                      
  benefit                                                                       
  (expense)                                                                     
  income                                                                        
  Interest                                -175          -186              -177  
  expense                                                                       
  Interest                                   6            10                 7  
  income                                                                        
  Dividend                                                                      
  income -                                  44            43                40  
  equity                                                                        
  investments                                                                   
  Other income                                                                  
  (expense),                                 6           -17                 4  
  net                                                                           
  Earnings                                                                      
  (loss) from                                                                   
  continuing                                93           142            -1,360  
  operations                                                                    
  before tax                                                                    
  Income tax                                                                    
  (provision)                              -14           -11                 7  
  benefit                                                                       
  Earnings                                                                      
  (loss) from                               79           131            -1,353  
  continuing                                                                    
  operations                                                                    
  Earnings                                                                      
  (loss) from                                                                   
  operation of                              -2            -2                 —  
  discontinued                                                                  
  operations                                                                    
  Income tax                                                                    
  (provision)                                                                   
  benefit from                               1             —                 —  
  discontinued                                                                  
  operations                                                                    
  Earnings                                                                      
  (loss) from                               -1            -2                 —  
  discontinued                                                                  
  operations                                                                    
  Net earnings                              78           129            -1,353  
  (loss)                                                                        
  Net                                                                           
  (earnings)                                                                    
  loss                                                                          
  attributable                              -4            -4                -4  
  to                                                                            
  noncontroll…                                                                  
  interests                                                                     
  Net earnings                                                                  
  (loss)                                                                        
  attributable                              74           125            -1,357  
  to                                                                            
  Celanese                                                                      
  Corporation                                                                   
  Amounts                                                                       
  attributable                                                                  
  to Celanese                                                                   
  Corporation                                                                   
  Earnings                                                                      
  (loss) from                               75           127            -1,357  
  continuing                                                                    
  operations                                                                    
  Earnings                                                                      
  (loss) from                               -1            -2                 —  
  discontinued                                                                  
  operations                                                                    
  Net earnings                              74           125            -1,357  
  (loss)                                                                        
  Earnings                                                                      
  (loss) per                                                                    
  common share                                                                  
  - basic                                                                       
  Continuing                              0.68          1.16            -12.39  
  operations                                                                    
  Discontinued                           -0.01         -0.02                 —  
  operations                                                                    
  Net earnings                                                                  
  (loss) -                                0.67          1.14            -12.39  
  basic                                                                         
  Earnings                                                                      
  (loss) per                                                                    
  common share                                                                  
  -                                                                             
  diluted                                                                       
  Continuing                              0.68          1.15            -12.39  
  operations                                                                    
  Discontinued                           -0.01         -0.02                 —  
  operations                                                                    
  Net earnings                                                                  
  (loss) -                                0.67          1.13            -12.39  
  diluted                                                                       
  Weighted                                                                      
  average                                                                       
  shares (in                                                                    
  millions)                                                                     
  Basic                                  109.8         109.8             109.6  
  Diluted                                110.2         110.2             109.6  
                                                                                
                                       8                                        
                                                                                
  Consolidated Balance Sheets - Unaudited                                       
                                                                                
                                                                                
                                As of                     As of                 
                                September 30,             December 31,          
                                2026                      2025                  
 ────────────────────────────────────────────────────────────────────────────── 
                                -In $ millions                                  
  ASSETS                                                                        
  Current Assets                                                                
  Cash and cash equivalents                      1,362                   1,263  
  Trade receivables - third                                                     
  party and                                        960                     922  
  affiliates, net                                                               
  Non-trade receivables, net                       624                     545  
  Inventories                                    2,286                   2,220  
  Assets held for sale                               —                     492  
  Other assets                                     258                     251  
  Total current assets                           5,490                   5,693  
  Investments in affiliates                      1,267                   1,252  
  Property, plant and                            4,715                   5,076  
  equipment, net                                                                
  Operating lease                                  426                     359  
  right-of-use assets                                                           
  Deferred income taxes                          1,279                   1,359  
  Other assets                                     571                     601  
  Goodwill                                       4,150                   4,171  
  Intangible assets, net                         3,036                   3,184  
  Total assets                                  20,934                  21,695  
  LIABILITIES AND EQUITY                                                        
  Current Liabilities                                                           
  Short-term borrowings and                                                     
  current                                                                       
  installments of long-term                      1,414                   1,204  
  debt - third                                                                  
  party and affiliates                                                          
  Trade payables - third                                                        
  party and                                      1,315                   1,279  
  affiliates                                                                    
  Liabilities held for sale                          —                      75  
  Other liabilities                              1,479                   1,049  
  Income taxes payable                             142                      76  
  Total current liabilities                      4,350                   3,683  
  Long-term debt, net of                                                        
  unamortized                                   10,131                  11,394  
  deferred financing costs                                                      
  Deferred income taxes                            369                     512  
  Uncertain tax positions                          222                     208  
  Benefit obligations                              312                     344  
  Operating lease                                  329                     265  
  liabilities                                                                   
  Other liabilities                                586                     817  
  Commitments and                                                               
  Contingencies                                                                 
  Shareholders' Equity                                                          
  Treasury stock, at cost                       -5,480                  -5,482  
  Additional paid-in capital                       459                     431  
  Retained earnings                             10,109                   9,876  
  Accumulated other                                                             
  comprehensive income                            -872                    -776  
  (loss), net                                                                   
  Total Celanese Corporation                                                    
  shareholders'                                  4,216                   4,049  
  equity                                                                        
  Noncontrolling interests                         419                     423  
  Total equity                                   4,635                   4,472  
  Total liabilities and                         20,934                  21,695  
  equity                                                                        
                                                                                
                                       9                                        

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CE/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.